Prognostic significance of circulating matrix metalloproteinase-2 to tissue inhibitor of metalloproteinases-2 ratio in recurrence of urothelial cancer after complete resection

Cancer Research

Volumn 56, Issue 14, 1996, Pages 3196-3198

  Gohji, Kazuo ^a   Fujimoto, Noboru ^b   Fujii, Akio ^c   Komiyama, Toyozo ^c   Okawa, Jiro ^c   Nakajima, Motowo ^d  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJI CHEMICAL INDUSTRIES LTD   (Japan)

^c HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^d International Research Laboratories   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; UROGENITAL TRACT TUMOR;

FEMALE; GELATINASES; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; METALLOENDOPEPTIDASES; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEINS; RECURRENCE; SURVIVAL ANALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; URINARY BLADDER NEOPLASMS;

EID: 0029908587     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Nakajima, M , and Chop, A M Tumor invasion and extracellular matrix degradative enzymes regulation of activity by organ factors. Semin Cancer Biol , 2: 115-127, 1991
2. Liotta, L. A , Steeg, P. S., and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis an imbalance of positive and negative regulation. Cell, 64: 327-336, 1991
3. Garbisa, S., Scagliotti, G., Masiero, L., Francesco, C. D , Caenazzo, C., Onisto, M , Micela, M., Stetler-Stevenson, W. G., and Liotta, L. A Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy. Cancer Res., 52: 4548-4549, 1992.
4. Stetler-Stevenson, W. G., Krutzsch, H C., and Liotta, L. A Tissue inhibitor of metalloproteinase (TIMP-2), a new member of the metalloproteinase inhibitor family. J Biol Chem., 264: 17374-17378, 1989.
5. DeClerck, Y. A , Perez, N., Shimada, H., Boone, T. C., Langley, K. E., and Taylor, S. M. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res., 52: 701-708, 1992.
6. Moses, M A., Sudhalter, J., and Langer, R Identification of an inhibitor of neovascularization from cartilage. Science, (Washington, DC), 248: 1408-1410, 1990
7. Montgomery, A. M P., Mueller, B. M., Reisfeld, R. A , Taylor, S. M., and DeClerck, Y. A. Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res., 54: 5467-5473, 1994.
8. Fujimoto, N., Mouri, N., Iwata, K., Ohuchi, E , Okada, Y., and Hayakawa, T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin. Chim. Acta, 221: 91-103, 1993
9. Fujimoto, N., Zhang, J , Iwata, K., Shinya, T., Okada, Y., and Hayakawa, T. A one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases-2 using monoclonal antibodies. Clin. Chim. Acta, 220: 31-45, 1993.
10. Koop, S., Khokha, R., Schmidt, E. E., MacDonald, I. C., Morris, V. L., Chambers, A. F., and Groom, A. C. Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res., 54: 4791-4797, 1994.